Prospect Financial Services LLC Invests $221,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Prospect Financial Services LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, Holdings Channel.com reports. The fund purchased 2,471 shares of the exchange traded fund’s stock, valued at approximately $221,000.

Other hedge funds have also recently bought and sold shares of the company. EPG Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 152.7% in the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after buying an additional 278 shares during the period. BOCHK Asset Management Ltd purchased a new position in SPDR S&P Biotech ETF in the 4th quarter worth approximately $36,000. Tennessee Valley Asset Management Partners acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $44,000. Wetzel Investment Advisors Inc. purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $45,000. Finally, Concourse Financial Group Securities Inc. lifted its position in shares of SPDR S&P Biotech ETF by 21.2% during the fourth quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock worth $59,000 after purchasing an additional 115 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock traded down $2.08 on Friday, hitting $91.74. The stock had a trading volume of 9,199,846 shares, compared to its average volume of 10,964,691. The stock’s 50 day moving average is $89.07 and its 200-day moving average is $89.62. The firm has a market capitalization of $6.99 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.